House Rx Secures $30 Million In Financing To Improve The Specialty Pharmacy Experience For Patients And Their Care Teams
PRIVATEMar 14, 2022
Amount Raised
$30 Million
Round Type
Funding Round
San FranciscoHealth Care
Description
House Rx, a health technology platform focused on improving affordability and patient access to specialty medications, today announced it has secured $25 million in Series A financing led by Bessemer Venture Partners, bringing total funding to $30 million.
Who to call at House Rx, and when
A new round usually means House Rx is about to hire and buy. The teams that reach out first get the meeting.
An alert the day House Rx raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at House Rx, from your own LinkedIn network
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Company Information
Company
House Rx
Location
San Francisco, California, United States
About
House Rx is a technology-enabled service company focused on making specialty medication more accessible and affordable. We do so by helping clinics dispense specialty medications to their patients in a medically-integrated way using pharmacist expertise and modern technology. By helping physicians and pharmacists collaborate on patient care, we’re able to improve patient outcomes, lower the cost of care, and create a better experience for patients and their caregivers.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment House Rx raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.